FCGRT and arthritic joint disease: Third, in the K/BxN serum transfer model of arthritis, prophylactic blockade of the FcRn by Fc‐engineered antibodies to block FcRn (Abdegs) impaired arthritis development, and in short‐term, quasi‐therapeutic settings also led to a delayed disease progression (Patel et al., 2011).